Ubs Global Asset Management Americas »

Madrigal Pharmaceuticals shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.3M 14k 231.38
2023-09-30 $2.3M 16k 146.04
2023-06-30 $3.7M 16k 242.26
2023-03-31 $3.7M 16k 242.26
2022-09-30 $1.1M 17k 64.99
2022-06-30 $1.2M 17k 71.58
2022-03-31 $1.2M 12k 98.12
2021-12-31 $1.1M 12k 84.74
2021-09-30 $992k 12k 79.79
2021-06-30 $1.2M 12k 97.41
2021-03-31 $1.4M 12k 116.97
2020-12-31 $1.1M 9.4k 118.73
2020-09-30 $1.1M 9.4k 118.73
2020-06-30 $976k 8.6k 113.25
2020-03-31 $240k 3.6k 66.76
2019-12-31 $641k 7.0k 91.11
2019-09-30 $318k 3.7k 86.22
2019-06-30 $322k 3.1k 104.81
2019-03-31 $385k 3.1k 125.26
2018-12-31 $316k 2.8k 112.72
2018-09-30 $851k 4.0k 214.13
2018-06-30 $1.3M 4.6k 279.69